Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by a cyclooxygenase 2 inhibitor (Celecoxib) and a 5-lipoxygenase inhibitor (Zileuton).

Ning Li; Xiaoxin Chen; Mingzhu Fang; Sandeep Sood; Chung S. Yang; Su Wang

Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by a cyclooxygenase 2 inhibitor (Celecoxib) and a 5-lipoxygenase inhibitor (Zileuton).

Ning Li(Shenzhen Third People’s Hospital), Xiaoxin Chen(Sun Yat-sen University), Mingzhu Fang(Rutgers, The State University of New Jersey), Sandeep Sood(Rutgers, The State University of New Jersey), Chung S. Yang(Rutgers, The State University of New Jersey), Su Wang(Rutgers, The State University of New Jersey)

Cancer Research

April 1, 2004

Cited by 0

|Environmental Health Perspectives|2003|2.1k

Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy

|Cell stem cell|2016|565

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

|Molecular Cancer|2024|412

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

|Journal of Hepatology|2019|364

Neonatal Chimerization with Human Glial Progenitor Cells Can Both Remyelinate and Rescue the Otherwise Lethally Hypomyelinated Shiverer Mouse

|Cell stem cell|2008|329

Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by a cyclooxygenase 2 inhibitor (Celecoxib) and a 5-lipoxygenase inhibitor (Zileuton).

Related Papers